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Abstract 
Purpose: To explore the activities of Bushen yixue decoction (BSY) against follicular development in 
anovulatory rats.  
Methods: Rats were divided into normal, normal control, clomifene citrate (positive control, orally, 5 
mg/kg), and BSY (orally, 50, 100, 200 mg/kg) groups. Anovulatory rats were prepared by testosterone 
propionate injection (1.5 mg/rat). After 70 days, daily vaginal smears were performed for 10 days until 
no obvious sexual cycle was observed, indicating that androgen-sterilized anovulatory rats were 
successfully established. High performance liquid chromatography (HPLC) was used to analyse BSY 
chemical composition. Levels of follicular stimulating hormone (FSH), luteinizing hormone (LH), 
oestradiol (E2), progesterone (P), prolactin (PRL), inhibin (INH), activin (ACT) and follistatin (FS) were 
determined by radioimmunoassay or enzyme linked immunosorbent assay (ELISA). Western blotting 
was used to determine Bcl-2, cleaved-caspase-3, Bax, MMP-9 and VEGF in ovarian tissues.  
Results: BSY increased (p < 0.05) the levels of FSH, LH, E2 (p < 0.05) and ACT, but decreased (p < 
0.05) the levels of PRL, INH and FS, relative to control rats. Expressions of VEGF (p < 0.01), MMP-9 (p 
< 0.05) and Bcl-2 (p < 0.01) were up-regulated by BSY, whereas Bax (p < 0.01) and C-caspase-3 (p < 
0.01) were down-regulated.  
Conclusion: BSY promotes follicular development of anovulatory rats via regulating INH-ACT-FS 
hormones, VEGF, MMP-9, Caspase-3, Bax, and Bcl-2. Thus, BSY may have the potential to be 
developed for clinical management of infertility. 
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Infertility is commonly defined as failure to 
conceive after 1 year of regular intercourse 
without contraception for women less than 35 
years old, and half a year for women more than 
35 years old. Nowadays, infertility has become a 
serious worldwide problem in reproductive health 
and causes psychological burdens both in 
individuals and couples [1-3]. Previous 
epidemiological studies reported that ovarian 
dysfunction can result in various problems, such 
as female endocrine disorders, continuous 
ovulation, less ovulation, inappropriate ovulation, 
polycystic ovary syndrome and 
hyperprolactinemia [4]. Importantly, it was shown 
that ovarian dysfunction is the most important 
cause of female infertility [2]. Normal follicular 
development is a pre-condition for ovulation and 
fertility. In recent years, researchers have found 
that follicular development in the normal 
menstrual cycle is closely associated with 
gonadotropins, such as follicular stimulating 
hormone (FSH), luteinizing hormone (LH), 
oestradiol (E2), progesterone (P), and prolactin 
(PRL), [5]. Follicular development is also closely 
related to the genes for angiogenesis, matrix 
metalloproteinases and apoptosis [6-9].  
 
In Chinese medicinal theory, it is commonly 
hypothesized that infertility is mainly related to 
deficiencies of the kidney, and nourishing the 
kidney and blood is therefore the primary therapy 
for treating infertility [10-12]. Based on this 
strategy, Bushen yixue decoction (BSY) is an 
effective prescription commonly used to treat 
infertility in China. BSY is mainly composed of 10 
traditional Chinese medicines (TCMs) (Table 1). 
However, knowledge of the chemical 
composition and pharmacological studies of BSY 
are incomplete. In this work, we determined the 
main chemical constituents of BSY and the 
activities of BSY on anovulatory rats induced by 
testosterone propionate. 
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Materials and reagents 
 
All crude TCMs were purchased from the Tong-
Ren-Tang Co., Ltd (Jinan, China). A series of 
voucher specimens (voucher no. 2014075-
2014085) was stored in our laboratory for future 
reference. Radioimmunoassay kits for FSH, LH, 
oestradiol (E2), progesterone (P), and prolactin 
(PRL) were purchased from Beijing Huaying 
Biotechnology Institute (Beijing, China). ELISA 
kits for inhibin (INH), activin (ACT), and follistatin 
(FS) were obtained from K-X Biotechnology 
(Shanghai, China). Primary antibodies against 
Bcl-2 and cleaved-caspase-3 (C-caspase-3) 
were purchased from Cell Signaling Technology 
(Beverly, MA, USA), and antibodies against Bax, 
MMP-9, VEGF, and β-actin and horseradish 
peroxidase (HPR) conjugated secondary 
antibodies were obtained from Abcam 
Biotechnology (Cambridge, MA, USA). Rutin, 
tiliroside, quercetin, kaempferide, safflomin A, 
hyperoside, and quercitrin were purchased from 
the National Institutes for Food and Drug Control 
(Beijing, China). 
 
Preparation of BSY 
 
The commonly used clinical prescription in China 
for BSY is composed of 10 TCMs (Table 1). All 
dried herbal medicines were mixed and decocted 
three times with boiling water (eight volumes of 
water each time; w/v) for 1 h and filtered. The 
filtrate was concentrated and dried under 
vacuum at 50°C to produce the dried BSY 
extracts. The yield of BSY extracts was 11.54 
%w/w. 
 
HPLC analysis of BSY 
 
BSY extracts were dissolved in methanol for 
HPLC assays. The analysis of chemical 
constituents in BSY extract was carried out on an 
Agilent Technologies 1200 system (Agilent, 
Santa Clara, CA, USA), and performed with a 
Diamonil C18 column (4.6 mm × 250 mm, 5 μm). 
The mobile phase was composed of acetonitrile 
(solvent A) and 0.3 % phosphoric acid (solvent 
B): 0 – 25 min (0 – 25 %, A), 20–40 min (25 – 40 
%, A), 40 – 75 min (40 – 80 %, A), 75 – 85 min 
(80 – 100 %, A). The sample injection volume 
was 20 μL, testing time was 85 min, and flow 
rate was 1 mL/min, column temperature was 30 




All animal experiments were in accordance with 
the National Institute of Health Guide for the 
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Care and Use of Laboratory Animals [13] and 
were approved by the Animal Care and Use 
Committee of the Center for Reproductive 
Medicine, Shandong Provincial Hospital Affiliated 
to Shandong University (no. 2014-S-1-5). 
Sprague Dawley (SD) female rats were obtained 
from the Shanghai Lab Animal Research Center 
(Shanghai, China). 
 
Determination of the acute toxicity of BSY 
 
The acute toxicity assays of BSY were carried 
out based on the method described in a previous 
report [14], with minor modifications. The rats 
were orally treated with a series of doses of BSY 
(10, 20, 40, 60, 80, 100, 150, 200, 400 and 600 
mg/kg), and acute toxicity was observed within 7 
days by calculating the LD50 value. The results 
indicated that there was no obvious acute toxicity 
in rats treated with 600 mg/kg of BSY. 
 
Animal model, grouping, and drug 
administration 
 
In total, 60 rats were divided into six groups: 
normal group, control group, clomifene citrate 
group (positive group) and three BSY (50, 100 
and 200 mg/kg BSY) groups (n = 10 per group). 
Anovulatory rats were prepared by subcutaneous 
injection of testosterone propionate (1.5 mg/rat, 
0.05 mL/rat) into the back of the neck of female 
SD rats (9-days-old). In addition, normal rats 
were injected with the same amount of distilled 
water. After 70 days, daily vaginal smears were 
performed, and no obvious sexual cycle was 
observed, which meant the androgen-sterilized 
anovulatory rat procedure was successfully 
established [15]. Then, the normal and control 
rats were orally treated distilled water (12 mL/kg), 
clomifene citrate (5 mL/kg) was treated orally for 
5 days, and BSY (50, 100, and 200 mg/kg) was 




The rats were weighed, anesthetised, and 
dissected from the abdomen, and then blood 
samples were collected and centrifuged at 3000 
rpm for 10 min to separate serum samples, 
which were freeze-dried immediately, and stored 
at −70 °C until analysis. After the aortic blood 
samples were collected, the rats were sacrificed 
using decollation, and the uterus and bilateral 
ovaries were collected and immediately weighed. 
 
Determination of serum hormone levels  
 
The serum levels of FSH, LH, E2, P, and PRL 
were analysed by commercial radioimmunoassay 
kits according to the manufacturer’s instructions. 
All assays were repeated at least three times. 
 
Determination of INH, ACT and FS  
 
The ovary tissues were homogenized and 
centrifuged at 3000 rpm for 10 min. 
Subsequently, the supernatants were used for 
determining the levels of INH, ACT, and FS using 
commercial ELISA kits, following the 
manufacturer’s instructions. 
 
Western blotting assay 
 
The ovary tissues were homogenized using a 
handheld tissue grinder, and the total proteins 
were collected. After determination of the protein 
concentration by a Bradford staining method, 30 
μg of denatured protein were separated by 
sodium dodecyl sulphate/polyacrylamide gel 
electrophoresis, and subsequently transferred 
onto polyvinylidene difluoride membranes, which 
were blocked with 5 % skim milk.  
 
Subsequently, the transferred protein bands 
were probed with primary antibodies against Bcl-
2, Bax, C-caspase-3, MMP-9, VEGF and β-actin 
(1:2000) overnight, and subsequently probed 
with HPR-conjugated secondary antibody. 
Finally, the protein bands were detected by 
chemiluminescence using a ChemiDoc 
XRS imaging system (Bio-Rad Laboratories, 
Hercules, CA, USA). To equalize the protein 





All data are presented as the mean ± SD. One-
way analysis of variance (ANOVA) was used to 
analyse the differences between two groups 
using SPSS, version 17.0 software (SPSS, 
Chicago, IL, USA). When p < 0.05, the difference 





Main chemical components of BSY 
 
Seven constituents, which included rutin, 
tiliroside, quercetin, kaempferide, safflomin A, 
hyperoside, and quercitrin were identified from 
BSY by using HPLC assays with reference 
compounds (Figure 1). The results indicated that 
flavone was one of the main active components 
of BSY. 
 




Figure 1: Main chemical components of BSY. (A): 
HPLC chromatograms of 7 standard compounds; (B): 
HPLC chromatogram of BSY sample. Peak 1: 
safflomin A, 2: tiliroside, 3: hyperoside, 4: rutin, 5: 
quercitrin, 6: quercetin and 7: kaempferide 
 
Effect of BSY on ovary and uterus indices of 
anovulatory rats 
 
After administration of testosterone propionate, 
the ovary and uterus indices of the rats were 
decreased (p < 0.01) (Figure 2). Within the 
positive group (clomifene citrate, 5 mL/kg), both 
the ovary and uterus indices of rats in the BSY 
treatment groups were significantly increased in 
a dose-dependent manner at doses of 100 and 
200 mg/kg (p < 0.01) when compared with the 
control rats. 
 
Effect of BSY on FSH, LH, E2, P, and PRL in 
the serum of anovulatory rats 
 
Compared with the normal rats, the contents of 
FSH, LH, and E2 were decreased (p < 0.01) for 
the anovulatory rats, whereas the PRL level was 
increased (p < 0.01) (Table 2). After treatment 
with clomifene citrate, the contents of FSH, LH, 
and E2 were markedly increased (p < 0.01), 
while the levels of PRL were decreased (p < 
0.01). Similarly, for the rats treated with BSY at 
doses of 100 and 200 mg/kg, the levels of FSH, 
LH, and E2 were increased (p < 0.05), and the 
PRL levels in the serum were decreased (p < 
0.05). However, no obvious difference was found 
in the serum level of P (p > 0.05) compared to 
control rats (Table 2). 
 
Effect of BSY on the INH-ACT-FS system of 
anovulatory rats 
 
The results of the present investigation showed 
that after injection of clomifene citrate (1.25 
mg/rat), the levels of INH and FS decreased (p < 
0.01) compared with the normal rats, whereas 
the levels of ACT in ovarian tissues increased (p 
< 0.01) vs. the control rats (Table 3). 
Interestingly, the results also demonstrated that 
BSY (50, 100, and 200 mg/kg) decreased the 
levels of FS (p < 0.01), whereas it increased the 
ACT (p < 0.01) compared with control rats. In 
addition, BSY at doses of 100 and 200 mg/kg 
also decreased the level of INH (p < 0.05). 
 
 
Figure 2: Effect of BSY on ovary and uterus index of 
anovulatory rats. Data were expressed as mean ± SD, 
each group consisted of 10 rats (n = 10). All the drugs 
were treated orally; **p < 0.01, compared with the 
control rats 
 
Table 2: Effect of BSY on the levels of FSH, LH, E2, P and PRL in anovulatory rats’ serum 
 
Group FSH (mIU/mL) LH (mIU/mL) E2 (pg/mL) P (ng/mL) PRL (ng/mL) 
Normal 11.23±0.68** 15.31±1.12** 152.91±21.91** 1.73±0.41 16.24±1.37** 
Control 9.69±0.83 12.14±1.05 130.28±18.22 1.65±0.51 20.94±1.56 
Positive  10.68±0.66* 14.59±1.25** 161.28±21.72** 1.58±0.44 15.87±1.81** 
50 mg/kg 10.15±0.74 14.51±1.34** 143.55±14.52* 1.43±0.49 18.43±1.33 
100 mg/kg 10.52±0.55* 14.93±1.32** 154.52±15.71* 1.52±0.43 17.71±1.02* 
200 mg/kg 10.79±0.54* 14.72±1.47** 162.95±11.74** 1.46±0.51 17.43±1.15* 
Data are expressed as mean ± SD (n = 10). All the drugs were treated orally; *p < 0.05, **p < 0.01, compared 
with the control group 
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Table 3: Effect of BSY on the INH, ACT and FS in ovarian tissue of anovulatory rats 
 
Group INH (mIU/mL) ACT (mIU/mL) FS (pg/mL) 
Normal 115.02±7.02** 88.03±19.91** 0.59±0.04** 
Control 133.67±8.93 55.01±16.74 1.32±0.22 
Positive 118.07±6.01** 87.96±21.32** 0.39±0.10** 
50 mg/kg 131.03±7.81 77.16± 8.98** 0.81±0.09** 
100 mg/kg 121.38±6.74* 96.44±15.79** 0.61±0.14** 
200 mg/kg 119.04±8.19* 103.61±19.95** 0.49±0.12** 
Data are expressed as mean ± SD, each group consisted of 10 rats (n =10). All the drugs were treated orally; *p 
< 0.05, **p < 0.01, compared with control group 
 
Effect of BSY on Bcl-2, Bax, C-caspase-3, 
MMP-9, and VEGF of anovulatory rats 
 
The results showed that protein expressions of 
Bcl-2, MMP and VEGF in ovarian tissues of 
anovulatory rats were significantly down-
regulated (p < 0.01), whereas the Bax and C-
caspase-3 proteins were up-regulated (p < 0.01), 
compared with the normal group (Figure 3). After 
treatment with BSY, the down-regulated protein 
expression levels of Bcl-2, MMP, and VEGF 
were increased (p < 0.05, p < 0.01, and p < 0.01, 
respectively) compared with the control rats. In 
addition, Bax and C-caspase-3 were decreased 
significantly by treatment with BSY at doses of 
50, 100, and 200 mg/kg (p < 0.01), compared 




Figure 3: Effect of BSY on Bcl-2, Bax, C-caspase-3, 
MMP-9 and VEGF in ovarian tissue of anovulatory 
rats. Data are expressed as mean ± SD, each group 
were consisted of 10 rats. All the drugs were treated 




BSY is one of the classical prescriptions for 
treating infertility in China, but in vivo animal 
experiments and chemical substance studies are 
still lacking. In the present study, the chemical 
constituents and pharmacological effects of BSY 
on androgen-sterilized anovulatory rats were 
determined. In addition, the possible 
pharmacological mechanisms of BSY were 
studied. 
 
Previous reports have shown that natural 
extracts/compounds from plants are important 
resources for finding novel and effective drugs to 
treat various intractable diseases [16-18]. 
Flavones are reported to possess significant 
pharmacological activities including anti-sterility, 
anti-inflammatory, and anti-cancer activities 
[19,20]. HPLC assay is a very useful way for 
analysis the chemical composition of herbal 
medicines [21,22]. In the present study, by using 
HPLC assays with reference agents, seven 
constituents were identified from BSY, including 
rutin, tiliroside, quercetin, kaempferide, safflomin 
A, hyperoside, and quercitrin, suggesting that 
flavones might be active constituents of BSY. 
 
The androgen-sterilized anovulatory rat is a 
classical experimental animal model used for 
investigating female fertility [15,23]. Normal 
follicular development is a pre-condition for 
ovulation and fertility. In recent years, studies 
have found that follicular development in the 
normal menstrual cycle is dependent on 
stimulation by gonadotropins such as FSH, LH, 
E2, P, and PRL [2,24]. FSH, LH, and E2 are 
necessary hormones for promoting follicular 
development and ovulation, whereas PRL is an 
inhibitory hormone [2]. In addition, FSH, LH, and 
E2 can also induce the aromatase activity of 
granulosa cells, leading to fission and 
proliferation of granular cells [2,25]. In the 
present investigation, the results suggested that 
BSY can significantly increase the levels of FSH, 
LH, and E2, whereas it decreased PRL levels. It 
was reported that gonadotropin biosynthesis is 
mainly regulated by the INH-ACT-FS system, 
and that the INH-ACT-FS system functional 
disorders might result in failure of oocyte 
maturation [25,26]. INH, closely related to the 
growth of ovarian granular cells, can inhibit the 
biosynthesis and secretion of FSH in the pituitary 
[15,27]. ACT promotes FSH secretion, granulosa 
cell differentiation of ovarian follicles, and 
formation of cavity follicles [28]. In addition, FS, a 
binding protein for ACT and INH, restrained the 
aromatizing enzyme activity of granule cells and 
inhibited FSH biosynthesis [29]. The results 
indicated that treatment with BSY increased the 
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levels of FSH, LH, and ACT, and decreased the 
levels of PRL, INH, and FS. These results further 
demonstrated that BSY extract improved follicle 
growth. In addition, the results also indicated that 
BSY promoted follicular development by 
regulating the INH-ACT-FS systems. 
 
New development of the ovary is important to 
guarantee the nutrient and hormone supplies 
necessary to promote follicular development and 
corpus luteum formation. VEGF is one of the 
most important initiators of angiogenesis in 
ovarian development [9]. In addition, it is 
reported that matrix metalloproteinases (MMP) 
play essential roles in extracellular matrix 
remodelling in ovarian follicle growth and 
ovulation [8]. Granulosa cells also play very 
important roles in ovarian follicle growth and 
ovulation, and excess granulosa cell apoptosis 
could induce decreased ovarian reserve and 
follicular atresia [6]. The results of the present 
study showed that VEGF and MMP-9 were up-
regulated by treatment with BSY. In addition, this 
study also indicated that treatment with BSY 
down-regulated pro-apoptosis proteins (caspase-
3 and Bax) in ovarian tissues but up-regulated 
the anti-apoptosis protein (Bcl-2). These results 
indicate that BSY treatment is beneficial for 
follicle growth and ovulation via regulating VEGF, 





BSY promotes follicular development by 
regulating the INH-ACT-FS system-related 
hormones, VEGF, MMP-9, Bcl-2, caspase-3, and 
Bax. However, the mechanism of action of BSY 
needs to be further investigated since the 
therapeutic effects of TCMs are the result of 
interactions of several pathways and targets. 
Collectively, the findings of this study suggest 
that BSY has potentials for use in the treatment 
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